Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men

被引:19
作者
Desai, MY
Santos, RD
Dalal, D
Carvalho, JAM
Martin, DR
Flynn, JA
Nasir, K
Blumenthal, RS
机构
[1] Johns Hopkins Univ, Sch Med, Ciccarone Prevent Cardiol Ctr, Dept Med & Rheumatol, Baltimore, MD 21287 USA
[2] Albert Einstein Hosp, Prevent Med Ctr, Sao Paulo, Brazil
[3] Univ Sao Paulo, Med Sch Hosp, Incor, Sao Paulo, Brazil
关键词
D O I
10.1016/j.amjcard.2004.12.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study in 352 asymptomatic middle-aged Brazilian men demonstrated that serum uric acid increases linearly with an increasing number (0 to >= 3) of metabolic risk factors (5.78 +/- 1.1, 6.14 +/- 1.0, 6.27 +/- 1. 1, and 6.79 +/- 1.3, p < 0.001). In patients who had >= 3 metabolic risk factors, there was a higher prevalence of serum uric acid in the highest quartile (7.2 to 10.3 mg/dl) than in the lowest quartile (2.6 to 5.4 mg/dl, 35% vs 12%, p < 0.001). Mean serum levels of uric acid were higher in those who had an abnormal ratio of >= 3 for triglyceride to high-density lipoprotein (suggesting insulin resistance) than in those who had a normal ratio (6.6 +/- 1.2 vs 5.87 +/- 1 mg/dl, p < 0.001). (c) 2005 by Excerpta Medica Inc.
引用
收藏
页码:865 / 868
页数:4
相关论文
共 20 条
[1]   Uric acid: role in cardiovascular disease and effects of losartan [J].
Alderman, M ;
Aiyer, KJV .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (03) :369-379
[2]   Pathogenesis and treatment of kidney disease and hypertension - Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study [J].
Athyros, VG ;
Elisaf, M ;
Papageorgiou, AA ;
Symeonidis, AN ;
Pehlivanidis, AN ;
Bouloukos, VI ;
Milionis, HJ ;
Mikhailidis, DP .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) :589-599
[3]  
BECKER BF, 1991, CHEST, V100, P176
[4]   Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country [J].
Conen, D ;
Wietlisbach, V ;
Bovet, P ;
Shamlaye, C ;
Riesen, W ;
Paccaud, F ;
Burnier, M .
BMC PUBLIC HEALTH, 2004, 4 (1) :1-9
[5]   Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension [J].
Feig, DI ;
Nakagawa, T ;
Karumanchi, SA ;
Oliver, WJ ;
Kang, DH ;
Finch, J ;
Johnson, RJ .
KIDNEY INTERNATIONAL, 2004, 66 (01) :281-287
[6]   RELATION OF BODY FATNESS AND ITS DISTRIBUTION TO CARDIOVASCULAR RISK-FACTORS IN YOUNG BLACKS AND WHITES - THE ROLE OF INSULIN [J].
FOLSOM, AR ;
BURKE, GL ;
BALLEW, C ;
JACOBS, DR ;
HASKELL, WL ;
DONAHUE, RP ;
LIU, K ;
HILNER, JE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 130 (05) :911-924
[7]   Varying body mass index cutoff points to describe overweight prevalence among US Adults: NHANES III (1988 to 1994) [J].
Kuczmarski, RJ ;
Carroll, MD ;
Flegal, KM ;
Troiano, RP .
OBESITY RESEARCH, 1997, 5 (06) :542-548
[8]   URIC-ACID AND CORONARY HEART-DISEASE RISK - EVIDENCE FOR A ROLE OF URIC-ACID IN THE OBESITY-INSULIN RESISTANCE SYNDROME [J].
LEE, J ;
SPARROW, D ;
VOKONAS, PS ;
LANDSBERG, L ;
WEISS, ST .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (03) :288-294
[9]  
McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007
[10]   Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women [J].
McLaughlin, T ;
Abbasi, F ;
Carantoni, M ;
Schaaf, P ;
Reaven, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) :578-581